In addition, OLR1 may be involved in reprogramming the lipid metabolism of tumour cells in HNSCC, thereby altering the tumour immune microenvironment and affecting the prognosis of patients41,42. The gene discussed is OLR1; the disease is head and neck squamous cell carcinoma.